Octanoic Acid

Octanoic Acid

SCHEMBL435382

CCCCCCCC(=O)O.Oc1c[nH]c2cc(Cl)c(Br)cc12

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.42
GSK3B P49841 1/20 0.42
GPR84 Q9NQS5 7/20 0.41
PPARG P37231 7/20 0.41
PPARD Q03181 7/20 0.41
PPARA Q07869 7/20 0.41
HDAC11 Q96DB2 5/20 0.41
TSHR P16473 4/20 0.41
PTPN1 P18031 3/20 0.41
ALDH1A1 P00352 2/20 0.41
TLR2 O60603 2/20 0.41
TDP1 Q9NUW8 2/20 0.41
FABP4 P15090 2/20 0.41
SLC22A6 Q4U2R8 1/20 0.41
SLC22A8 Q8TCC7 1/20 0.41
MEN1 O00255 1/20 0.41
ESR1 P03372 1/20 0.41
ALOX15 P16050 1/20 0.41
PDE4A P27815 1/20 0.41
KMT2A Q03164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Nonanoate SCHEMBL27808330 1.00 CYP1A2 (0.42) CYP1A2GSK3BGPR84PPARGPPARD
Palmitic Acid SCHEMBL432626 1.00 CYP1A2 (0.42) CYP1A2GSK3BGPR84PPARGPPARD
Decanoic Acid SCHEMBL4214099 1.00 CYP1A2 (0.42) CYP1A2GSK3BGPR84PPARGPPARD
Octanoic Acid SCHEMBL3890252 0.90 TRPV1 (0.37) CYP1A2GSK3BGPR84PPARGPPARD
Nonanoate SCHEMBL27828783 0.81 GPR84 (0.42) GSK3BGPR84PPARGPPARDPPARA
Palmitic Acid SCHEMBL432580 0.81 GSK3B (0.47) GSK3BGPR84PPARGPPARDPPARA
Nonanoate SCHEMBL27828760 0.81 GSK3B (0.47) GSK3BGPR84PPARGPPARDPPARA
Octanoic Acid SCHEMBL8441356 0.81 GSK3B (0.47) GSK3BGPR84PPARGPPARDPPARA
Octanoic Acid SCHEMBL2155766 0.81 GSK3B (0.47) GSK3BGPR84PPARGPPARDPPARA
Octanoic Acid SCHEMBL27808356 0.81 GPR84 (0.42) GSK3BGPR84PPARGPPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230348385-A1 POLYMORPHS OF 5-BROMO-6-CHLORO-3-INDOXYL CAPRYLATE BIOSYNTH AG (CH) 2023-11-02 US claimed
EP-4196465-A1 POLYMORPHS OF 5-BROMO-6-CHLORO-3-INDOXYL CAPRYLATE Biosynth AG (CH) 2023-06-21 EP claimed
WO-2022038120-A1 POLYMORPHS OF 5-BROMO-6-CHLORO-3-INDOXYL CAPRYLATE BIOSYNTH AG (CH) 2022-02-24 WO claimed
US-20200298233-A1 MICROFLUIDIC PAPER CHIP FOR DETECTING MICRO-ORGANISM, METHOD FOR PREPARING THE SAME AND METHOD FOR DETECTING MICRO-ORGANISM USING THE SAME BIOMAX CO., LTD. (KR) 2020-09-24 US claimed
CN-101395278-B Method for identifying at least two groups of microorganisms BIOMERIEUX SA 2013-10-23 CN claimed
EP-2588219-B1 FILTER PLATE ARTICLE HAVING A WATER-ABSORBENT FILTER ASSEMBLY NEOGEN FOOD SAFETY US HOLDCO CORP (US) 2024-05-29 EP disclosed
US-20230348385-A1 POLYMORPHS OF 5-BROMO-6-CHLORO-3-INDOXYL CAPRYLATE BIOSYNTH AG (CH) 2023-11-02 US disclosed
US-20230348385-A1 POLYMORPHS OF 5-BROMO-6-CHLORO-3-INDOXYL CAPRYLATE BIOSYNTH AG (CH) 2023-11-02 US disclosed
EP-4196465-A1 POLYMORPHS OF 5-BROMO-6-CHLORO-3-INDOXYL CAPRYLATE Biosynth AG (CH) 2023-06-21 EP disclosed
EP-4196465-A1 POLYMORPHS OF 5-BROMO-6-CHLORO-3-INDOXYL CAPRYLATE Biosynth AG (CH) 2023-06-21 EP disclosed
WO-2022038120-A1 POLYMORPHS OF 5-BROMO-6-CHLORO-3-INDOXYL CAPRYLATE BIOSYNTH AG (CH) 2022-02-24 WO disclosed
WO-2022038120-A1 POLYMORPHS OF 5-BROMO-6-CHLORO-3-INDOXYL CAPRYLATE BIOSYNTH AG (CH) 2022-02-24 WO disclosed
CN-1902323-A Medium for detecting and identifying microorganism BIOMERIEUX SA (FR) 2007-01-24 CN disclosed
US-20060257966-A1 Medium for detection and identification of micro-organisms BIOMERIEUX (FR) 2006-11-16 US disclosed
CN-1768150-A Method for the detection and/or identification of bacteria present in a sample BIOMERIEUX SA (FR) 2006-05-03 CN disclosed
EP-1611246-A2 MEDIUM FOR THE DETECTION AND IDENTIFICATION OF MICRO-ORGANISMS BIOMERIEUX (FR) 2006-01-04 EP disclosed
WO-2004092400-A2 MEDIUM FOR THE DETECTION AND IDENTIFICATION OF MICRO-ORGANISMS BIOMERIEUX (FR) 2004-10-28 WO disclosed
US-6090541-A Method and device for detecting bacteriophage using contrast-coloring and precipitable dyes 3M INNOVATIVE PROPERTIES COMPANY (US) 2000-07-18 US disclosed
US-6004769-A COMPOSITIONS AND PROCEDURES FOR THE DETERMINATION OF HYDROLYTIC ENZYMES IN LIQUID SAMPLES WITH THE AID OF INDOXYL COMPOUNDS AND OXIDIZING AGENTS MERCK PATENT GESELLSCHAFT (DE) 1999-12-21 US disclosed
US-5958675-A Method for detecting bacteria using bacteriophage, contrast-coloring dye and precipitable dye 3M INNOVATIVE PROPERTIES COMPANY (US) 1999-09-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230348385-A1 POLYMORPHS OF 5-BROMO-6-CHLORO-3-INDOXYL CAPRYLATE IPO4, NCBP2, RCC1 CYP1A2 569/4885GSK3B 2301/4885GPR84 4853/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.